Trovagene Highlights Response To Treatment In Patients Enrolled In Phase 1b/2 Trial Of Onvansertib In Combo With FOLFIRI, Avastin: Decreases In Tumor KRAS Mutational Burden In Response To Treatment Was Observed In All 4 Patients Who Completed First Cycle